Skip to NavigationSkip to content

News

Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE...
The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients of the Moderna Inc and...
The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. 
The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERA™ COVID-19 Ag Test. 
UK Ministers are considering the implementation of a COVID ‘Plan C’. Cabinet Office officials are said to be discussing proposals which could form...
Open Orphan has announced that they are progressing with their government-backed COVID-19 vaccine human challenge study.
Novartis announced today that it has signed an initial agreement with BioNTech SE to expand its support of the fill-and-finish of the Pfizer-BioNTech...
Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its lead N,N-dimethyltryptamine (DMT)...
Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its lead N,N-dimethyltryptamine (DMT)...
IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI data...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches